Anyplex Ensaio HPV 28 Detection Seegene Brazil

Anyplex™ II
HPV28 Detection

Detecção simultânea e identificação de 28 tipos de HPV (19 de alto risco e 9 de baixo risco)

Certificações: CE e ANVISA

Anyplex™ II HPV28 Detection simultaneamente detecta, diferencia e quantifica 28 genótipos distintos de HPV (19 de alto risco e 9 de baixo risco) responsáveis pelo câncer do colo do útero e/ou infecções sexualmente transmissíveis. Baseado na tecnologia exclusiva da Seegene MuDT™, esse ensaio é feito em equipamentos de PCR em tempo real e fornece informação genotípica de alta sensibilidade e especificidade de 28 tipos de infecção por HPV em uma única reação.

CARACTERÍSTICAS

PCR em tempo real - Seegene do Brazil
PCR em tempo real multiplex

Detecção de 14 tipos genotípicos de HPV de alto risco em uma única reação.

Monitoramento útil

Ferramenta útil para o monitoramento e controle de infecções.

Analisador automático de dados
Analisador automatizado de dados

Interpretação automatizada de dados e interligação com LIS utilizando o Seegene Viewer.

Sistema UDG
Sistema UDG

Utilização do Sistema UDG para prevenir contaminação por carregamento.

Análise quantitativa

Análise quantitativa através de cyclic-CMTA.

Fluxo de trabalho intuitivo - Seegene Brazil
Fluxo de trabalho amigável ao usuário

Fluxo de trabalho prático utilizando a plataforma única automatizada Seegene.

Validação do processo completo

Validação do processo completo da extração à PCR através de controle do processo completo.

Testes informativos
Ensaio informativo

Assistência no tratamento apropriado e gerenciamento de coinfecções.

Desempenho poderoso com tecnologia exclusiva

PCR em tempo real multiplex com alta sensibilidade e especificidade utilizando as tecnologias DPO™ e TOCE™.

ANALITOS

19 tipos de HPV de alto risco

  • Papilomavírus Humano 16 (HPV 16)
  • Papilomavírus Humano 18 (HPV 18)
  • Papilomavírus Humano 26 (HPV 26)
  • Papilomavírus Humano 31 (HPV 31)
  • Papilomavírus Humano 33 (HPV 33)
  • Papilomavírus Humano 35 (HPV 35)
  • Papilomavírus Humano 39 (HPV 39)
  • Papilomavírus Humano 45 (HPV 45)
  • Papilomavírus Humano 51 (HPV 51)
  • Papilomavírus Humano 52 (HPV 52)
  • Papilomavírus Humano 53 (HPV 53)
  • Papilomavírus Humano 56 (HPV 56)
  • Papilomavírus Humano 58 (HPV 58)
  • Papilomavírus Humano 59 (HPV 59)
  • Papilomavírus Humano 66 (HPV 66)
  • Papilomavírus Humano 68 (HPV 68)
  • Papilomavírus Humano 69 (HPV 69)
  • Papilomavírus Humano 73 (HPV 73)
  • Papilomavírus Humano 82 (HPV 82)
  • Controle Interno (CI)

9 tipos de HPV de baixo risco

  • Papilomavírus Humano 11 (HPV 11)
  • Papilomavírus Humano 40 (HPV 40)
  • Papilomavírus Humano 42 (HPV 42)
  • Papilomavírus Humano 43 (HPV 43)
  • Papilomavírus Humano 44 (HPV 44)
  • Papilomavírus Humano 54 (HPV 54)
  • Papilomavírus Humano 6 (HPV 6)
  • Papilomavírus Humano 61 (HPV 61)
  • Papilomavírus Humano 70 (HPV 70)
  • Controle Interno (CI)

ESPÉCIMES

  • Esfregaço cervical.
  • Citologia em meio líquido (ex. ThinPrep® e Surepath™).

INFORMAÇÕES SOBRE PEDIDO

Produto

Anyplex™ II HPV28 Detection
Registro ANVISA: 80102512187

Cat. nº/Tamanho

HP7S00X / 100 reações

RESULTADOS

Anyplex II HPV28 Detection Seegene Brazil

Os resultados representam coinfecções onde a carga de HPV 16 está alta (+++) no canal HEX, HPV 52 está alta (+++) no canal Cal Red 610, HPV 35 e 61 estão altas (+++) no canal Quasar 670 e HPV 40 está intermediária (++) no canal Quasar 705.

PUBLICAÇÕES

– Esophageal squamous cell carcinomas in a Malaysian cohort show a lack of association with human papillomavirus

– Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic

– Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies

– Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016

– HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples

– Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings

– Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection

– Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana

– Prevalence of human papillomavirus and bacteria as sexually transmitted infections in symptomatic and asymptomatic women

– Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala

– Prevalence of human papillomavirus infection among women in rural Nepal

– Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

– No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population

– HPV Genotyping from the high risk mRNA Aptima assay- a direct approach using DNA from Aptima sample tubes

– Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus

– Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus

– Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer

– Human Papillomavirus Prevalence and Type Distribution Among 968 Women in South Korea

– Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas

– Use of swabs for dry collection of selfsamples to detect human papillomavirus among Malagasy women

– Multiple Human Papillomavirus Infection Is Associated with High-Risk Infection in Male Genital Warts in Ulsan, Korea

– Genotypic characterisation of human papillomavirus infections among persons living with HIV infection; a case–control study in Kumasi, Ghana

– Evaluation of HPV genotyping assays for archival clincal smaples

– Performance evaluation of Anyplex™II HPV28 detection kit in a routine diagnostic setting: Comparison with the HPV Sign® Genotyping Test

– Clincal validation of the Anyplex II HPV HR Detection for the Cervical Cancer Screening

– Type-specific persistence or regression of human papillomavirus genotypes in women with cervical intraepithelial neoplasia 1: A prospective cohort study

– A case of HPV-53-related cervical cancer in an elderly patient

– Updating the PGMY primers and probes for improved detection of HPV68a: validation of version 2 of the PGMY-CHUV assay

– High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection

– Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection

– A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology

– Human papillomavirus genotyping: comparison of the Seegene AnyplexTM II HPV28 with the PGMY-CHUV assay

– Comparative Evaluation of the HPV28 Detection and HPV DNA Chip Test for Detecting and Genotyping Human Papillomaviruses

– Prevalence of Human Papillomavirus Infection and Genotype Distribution Determined by the Cyclic-Catcher Melting Temperature Analysis in Korean medical checkup population